| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8686367 | Neurobiology of Disease | 2018 | 10 Pages |
Abstract
Our findings demonstrate, for the first time, that LCM targets GABAA receptors and that it can act synergistically with LEV, improving the GABAergic function. This novel mechanism might contribute to explain the clinical efficacy of LCM-LEV combination in several refractory epileptic patients.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Gabriele Ruffolo, Carlo Di Bonaventura, Pierangelo Cifelli, Cristina Roseti, Jinane Fattouch, Alessandra Morano, Cristina Limatola, Eleonora Aronica, Eleonora Palma, Anna Teresa Giallonardo,